TALS Historical PE Ratio image   This TALS PE ratio history page last updated 11/11/2022
TALS PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
1.53-0.46-1.35NA
Q2 2022
8/15/2022
4.85-0.44-1.24NA
Q1 2022
5/12/2022
5.96-0.45-1.12NA
Q4 2021
3/17/2022
7.96-0.35-0.67NA
Q3 2021
11/12/2021
15.98-0.32-2.03NA
Q2 2021
8/12/2021
13.79-0.41NANA
Q1 2021
6/14/2021
17.47-1.30NANA
TALS Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
1.53-0.46-1.84NA
Q2 2022
8/15/2022
4.85-0.44-1.76NA
Q1 2022
5/12/2022
5.96-0.45-1.80NA
Q4 2021
3/17/2022
7.96-0.35-1.40NA
Q3 2021
11/12/2021
15.98-0.32-1.28NA
Q2 2021
8/12/2021
13.79-0.41-1.64NA
Q1 2021
6/14/2021
17.47-1.30-5.20NA
Quotes delayed 20 minutes

Email EnvelopeFree TALS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Talaris Therapeutics (TALS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

TARA PE Ratio History
TARS PE Ratio History
TBIO PE Ratio History
TCDA PE Ratio History
TCMD PE Ratio History
TCON PE Ratio History
TCRR PE Ratio History
TCRT PE Ratio History
TCRX PE Ratio History
TDOC PE Ratio History
On this page we presented the TALS PE Ratio History information for Talaris Therapeutics' stock. The average TALS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TALS PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TALS PE ratio history result, against the recent PE: when this page was posted on 11/10/2022, the most recent closing price for TALS had been 1.53, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on TALS or any other given stock, valuation analysis for TALS can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Talaris Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for TALS. Thanks for visiting, and the next time you need to research TALS PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: AGEN Options Chain, AVNT Options Chain, Institutional Holders of ZF.

 

TALS PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.